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Blinded Comparison of Repetitive-Sequence PCR and Multilocus
Sequence Typing for Genotyping Methicillin-Resistant
Staphylococcus aureus Isolates from a Children’s
Hospital in St. Louis, Missouri
Robert S. Liao,1† Gregory A. Storch,2 Richard S. Buller,2 Rachel C. Orscheln,2
Elaine R. Mardis,3 Jon R. Armstrong,3 and W. Michael Dunne, Jr.1*
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We performed a blinded study to compare repetitive-sequence PCR and multilocus sequence typing for
genotyping hospital- and community-acquired methicillin-resistant Staphylococcus aureus (MRSA). The MRSA
strains that were sequence type 8 (ST8), staphylococcal cassette chromosome mec (SCCmec) type IV, and
Panton-Valentine leukocidin-positive clustered separately from those that were ST5 and SCCmec type II.
Until recently, Staphylococcus aureus infections in the com-
munity were caused mostly by methicillin-susceptible S. aureus
(MSSA) strains, and the dissemination of hospital-acquired
methicillin-resistant S. aureus (HA-MRSA) into the commu-
nity was infrequent (21). However, since the mid-1990s, there
have been increased reports of community-acquired MRSA
(CA-MRSA) infections in otherwise healthy community-dwell-
ing adult and pediatric patients who do not share the known
risk factors for MRSA colonization (13, 22). CA-MRSA iso-
lates have been shown to contain a unique genetic element
called staphylococcal cassette chromosome mec (SCCmec)
type IV and V (17). These isolates are frequently clindamycin
susceptible and have a narrower antibiotic resistance pattern
than HA-MRSA (21). In addition, CA-MRSA isolates are
isolated commonly from skin and soft-tissue infections (13)
and possess genes encoding the Panton-Valentine leukocidin
(PVL) toxin (25).
Twenty-eight clinical isolates of S. aureus were obtained
from individual pediatric patients between January 2002 and
January 2004. These isolates were identified as S. aureus by the
clinical laboratory with standard methods, using Gram’s stain,
catalase, and Staphaurex latex agglutination (Remel, Lenexa,
KS) (1). Susceptibility testing was performed by the clinical
laboratory using the CLSI (formerly NCCLS) guidelines for
disk diffusion susceptibility testing (15). For the purpose of this
study, two definitions of CA and HA were used. One definition
was based on the susceptibility phenotype, in which clindamy-
cin-susceptible strains, including those shown to have inducible
clindamycin resistance, were considered to be CA. Clindamy-
cin-resistant strains were assumed to be HA. The second def-
inition was based on day of acquisition. For the latter, MRSA
strains were considered to be CA if the cultures were positive
in an outpatient setting or within 48 h of hospitalization.
Strains that were recovered from patients after 48 h of hospi-
talization were defined as HA. The study set was chosen to
contain representative CA and HA strains based on either
definition.
Prior to PCR genotyping, individual clinical isolates were
grown overnight in trypticase soy broth. The cells were centri-
fuged, and the DNA was purified from the pellets using the
extraction method described by Kalia et al. (9) in combination
with a QIAamp genomic DNA extraction kit (QIAGEN, Inc.,
Chatsworth, CA). Repetitive-sequence PCR (rep-PCR) typing
using the RW3A primer sequences was performed according
to the procedure of Del Vecchio et al. (4) and with Ready-
To-Go randomly amplified polymorphic DNA analysis beads
(Amersham Biosciences, Piscataway, NJ). To investigate the
prevalence of resistance determinants, PCR amplification for
known resistance genes was performed using Ready-To-Go
randomly amplified polymorphic DNA analysis beads (Amer-
sham Biosciences). PCR detections of the ermA (10), ermC
(10), msrA (12), aacA-aphD (24), mecA (24), and lukS-PV-
lukF-PV (8) genes were performed using the primers and ther-
mal cycling profile previously described. Typing of the staphy-
lococcal chromosome mec element was done using a multiplex
real-time PCR assay described by Francois et al. (7) using an
Applied Biosystems 7300 real-time PCR system (Applied Biosys-
tems, Foster City, CA). For multilocus sequence typing (MLST),
PCRs using S. aureus genomic DNA isolates were performed as
described previously (6). PCR fragments of the seven housekeep-
ing genes, arcC, aroE, glpF, gmk, pta, tpi, and yqiL, were obtained
from chromosomal DNA and were directly sequenced. The se-
quencing reactions were cycled in a PTC-225 (MJ Research, Wal-
tham, MA) and loaded onto a 3730xl DNA analyzer (Applied
Biosystems, Foster City, CA).
Rep-PCR genotyping was performed blinded to the source
of the study isolates or their susceptibility profiles, MLST se-
quence types (STs), or SCCmec types. Each strain was classi-
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† Present address: Pathology and Molecular Medicine, Kingston
General Hospital, Douglas 3, Room 315, 76 Stuart Street, Kingston,
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fied using the nomenclature put forward by Enright et al. of
naming MRSA clones according to their MLST-resistance
phenotype-SCCmec types (5). The majority of the 28 strains of
MRSA belonged to two epidemic clones that were identified as
ST5 (1-4-1-4-12-1-10)-MRSA-II (9 strains) and ST8 (3-3-1-1-
4-4-3)-MRSA-IV (15 strains). The two MSSA strains that were
included in this study were also ST8. Historical designations
previously given to ST8-MRSA-IV and ST5-MRSA-II are New
York/Japan and Clone V (or New York clone V), respectively.
Three additional SCCmec type II strains of MRSA (Sa229,
Sa235, and Sa386) had allelic profiles that represented two
novel ST entries in the database. These novel profiles, 1-36-1-
4-12-1-10 and 1-4-1-4-12-1-80, most closely resembled the al-
lelic profile for ST5 after a comparison utilizing the MLST
website (http://saureus.mlst.net). A single MRSA strain,
Sa221, was shown to be ST72 (1-4-1-8-4-4-3) using MLST.
Although this strain was positive for the mec gene, it could not
be SCCmec typed. RW3A rep-PCR of the 28 MRSA strains
produced two distinct clusters of strains that correlated
strongly with MLST-SCCmec type (Fig. 1) and the presence or
absence of the msrA and erm resistance genes. Quantitative
analyses of the RW3A rep-PCR products show that the clus-
ters shared less than 60% similarity.
One of the two clusters contained all 15 of the ST8-
MRSA-IV strains. The strains of this ST8-MRSA-IV cluster
also included all of the PVL-positive strains with the exception
of a single strain, Sa384. These ST8-MRSA-IV strains have an
overall similarity of 92% based on the comparison of amplified
RW3A rep-PCR products (Fig. 1). Ninety percent of the ST8-
MRSA-IV strains were determined to be from abscesses from
the lower extremities.
The second cluster was composed of the single ST72 strain
and the 12 SCCmec type II strains that included the 9 ST5-
SCCmec-II strains plus the 3 strains with closely related but
novel ST types (Sa229, Sa235, and Sa386). The strains of this
SCCmec type II cluster were uniformly PVL negative and
shared 88% similarity (Fig. 1). Ten of the 13 strains in the
SCCmec type II cluster were from respiratory specimens.
Strain Sa221 (ST72-SCCmec nontypeable) shared only 80%
similarity with the other strains in the PVL-negative SCCmec
type II cluster.
The 28 strains that compose the SCCmec type II and ST8-
MRSA-IV clusters also correlated strongly with the presence
or absence of the msrA and erm resistance genes. The msrA
gene was present in 13 of the 15 ST8-MRSA-IV strains,
compared to 0 of the 13 SCCmec type II strains. In contrast,
the erm gene was present in all 13 strains of the SCCmec
type II cluster, although 4 of the ST8-MRSA-IV strains also
possessed erm.
MLST is a powerful genotyping method that is usually ap-
plied to the evaluation of evolutionary relationships because
the variation that is quantified accumulates more slowly as a
FIG. 1. Cluster analysis of PCR products from all 28 strains of MRSA using repetitive-sequence PCR with RW3A primers. The presence of
the PVL gene is indicated by () and the absence by (). MLST results are indicated by allelic profile, and newly identified genotypes are indicated
by “New.” SSCmec typing results that are not determined are indicated with ND. SSCmec typing results II and IV are indicated by II and IV. The
two columns labeled EpiS and EpiT differentiate strains that were determined to be CA or HA based on susceptibility phenotype and day of
acquisition, respectively.
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result of the neutral mutations. As a consequence, isolates with
the same ST may be identified as members of the same clone
but have very different pulsed-field gel electrophoresis (PFGE)
patterns (6). PCR-based genotyping methods, such as RW3A
rep-PCR, and PFGE detect genetic events in MRSA that occur
on a shorter time scale (23). While rep-PCR has been shown to
have high discriminatory power as well as reproducibility for
genotyping MRSA, the method is still regarded as having less
discriminatory power than PFGE (23). As a consequence,
there have been very few direct comparisons between rep-PCR
and MLST for genotyping bacteria. This blinded study com-
pared a collection of 28 HA- and CA-MRSA strains using
rep-PCR and MLST. The RW3A rep-PCR genotyping method
was reproducible and generated highly discriminatory frag-
ment patterns. The success obtained with rep-PCR in separat-
ing HA and CA-MRSA strains was due in large part to the fact
that the ST8-MRSA-IV (Clone V) and ST5-MRSA-II (New
York/Japan) clones have been shown to have very different
chromosomal backgrounds (20).
Nine of the 13 strains that composed the SCCmec type II
cluster, as determined by RW3A rep-PCR, were ST5-MRSA-
II. ST5-MRSA-II is a well described pandemic clone of HA-
MRSA and is the dominant clone in hospitals in Miami, New
York, New Jersey, Pennsylvania, and Connecticut (19). The 13
strains in the SCCmec type II cluster shared several traits that
are commonly attributed to HA-MRSA clones (22): having
clindamycin resistance and causing serious invasive infections.
All 13 of the strains in the SCCmec type II cluster were clin-
damycin resistant; 4 of these strains were also resistant to
gentamicin. Additionally, 10 of these strains were isolated from
respiratory specimens, which is a common body site for hospi-
tal-acquired infections. Of note, half of the strains belonging to
the SCCmec type II cluster could not be distinguished as pos-
sible HA-MRSA strains from a determination based on day of
acquisition. Thus, the epidemiology associated with these 28
strains of MRSA proved to be less reliable than the informa-
tion obtained by PCR and genotyping for making a determi-
nation of CA- versus HA-MRSA infections.
Strain Sa221 was determined to be ST72 by using MLST and
shared only 80% similarity to the ST5-MRSA-II strains. Un-
fortunately, the SCCmec element for Sa221 could not be de-
termined; however, ST72-MRSA-IV has been described as a
cause of CA-MRSA infections in Miami (3), San Francisco (2),
and Mississippi (18). ST72-MRSA-IV belongs to CC8 and has
also been designated pulsed-field type USA700 (14).
RW3A rep-PCR grouped all 15 MRSA strains determined
to be ST8 into the ST8-MRSA-IV cluster. The ST8-MRSA-IV
strains shared several traits known to be common to CA-
MRSA clones (25). Fourteen of the 15 ST8-MRSA-IV strains
were isolated from skin and soft-tissue infections and pos-
sessed the PVL toxin. In addition, 13 of these 15 ST8-
MRSA-IV strains, 12 of which were susceptible to clindamycin,
possessed the msrA gene. Interestingly, two strains of PVL-
positive ST8 MSSA were also genotyped using RW3A rep-
PCR, and these strains shared a greater-than-90% similarity
with the ST8-MRSA-IV cluster. ST8-MRSA-IV is an epidemic
clone of CA-MRSA that exists in the United States and has
been designated pulsed-field type USA300 (14). USA300 is
present in diverse regions of the United States, where it has
been identified in community onset MRSA outbreaks associ-
ated with skin and soft-tissue infections in athletic teams, cor-
rectional facilities, and nurseries (14).
The presence or absence of the PVL determinant consis-
tently distinguished the SCCmec type II cluster from the ST8-
MRSA-IV cluster as determined by RW3A rep-PCR, with the
exception of a single PVL-negative, ST8-MRSA-IV strain,
Sa384. Despite the fact that the PVL gene has been described
as a stable genetic marker of CA-MRSA strains (25), the
current understanding of SCCmec type IV CA-MRSA dictates
that its detection worldwide must consider that not all com-
munity-acquired MRSA strains will possess the PVL gene (11).
Interestingly, the Sa384 strain shared the same MLST allelic
profile as the other ST8-MRSA-IV strains in the SCCmec type
IV cluster, indicating that these strains share a common evo-
lutionary pathway. Strain Sa384 differed from the CA-MRSA
ST8-MRSA-IV strains in being obtained from a lower-respi-
ratory specimen (bronchoalveolar) and having multidrug resis-
tance to clindamycin, gentamicin, and trimethoprim-sulfameth-
oxazole (18, 25). To date, most SCCmec IV CA-MRSA isolates
have had MLST allelic profiles that are not found in studies of
HA-MRSA (18). However, CA-MRSA has the potential to move
into the hospital setting and cause outbreaks (16). This study
reiterates that the detection of SSCmec type IV CA-MRSA does
not guarantee PVL production or predictable resistance profiles.
Other investigators have reported that the relative frequen-
cies of S. aureus erm genes are not the same worldwide or static
over time and that different erm genes have been found in
different S. aureus clones (26). Among our MRSA isolates,
there was a strong predominance of the ermA over the ermC
determinant. In our study, the only 2 MRSA strains that pos-
sessed the ermC gene, Sa221 and Sa384, were remarkably dif-
ferent from the other strains in their respective clusters, and
ermC could be used as a marker for genetic variation in this
group of CA-MRSA isolates.
The results of MLST and SCCmec typing and the detection
of genes that encode PVL and macrolide/lincosamide resis-
tance were very encouraging in suggesting the strength of rep-
PCR for separating this collection of strains into HA- and
CA-MRSA. RW3A rep-PCR should be investigated further to
determine whether this inexpensive and rapid method of geno-
typing can be used by individual laboratories to follow the
dissemination of CA-MRSA SCCmec type IV isolates.
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